MAKO Surgical Corp. Introduces MAKOplasty(R) Total Hip Arthroplasty

Robotic Arm-Assisted Technology Provides Surgeons With Consistently Reproducible Precision in Hip Replacement Surgery

MAKOplasty Total Hip Arthroplasty is Designed to Help Surgeons Restore Patient Mobility and Lifestyle

MAKO Surgical Corp. (Nasdaq:MAKO - News) today announced the commercial availability of the RIO(R) Robotic Arm Interactive Orthopedic System for use in total hip replacement procedures, called MAKOplasty(R) Total Hip Arthroplasty.

Published: 19 September 2011
Written by Editor
Nasdaq   Healthcare   Project Updates   Up on News   Interesting News  
Read more: MAKO Surgical Corp ( MAKO )

Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company

Natus Medical Incorporated (Nasdaq:BABY) today announced that it has acquired Embla Systems LLC, a leader in the development, manufacturing, and sales of devices used in the diagnosis of sleep apnea. Embla is the largest company in the world focused solely on sleep diagnostics (Polysomnography or PSG and Home Sleep Testing). The company offers a wide spectrum of innovative sleep diagnostic solutions including Embletta home sleep testing devices and three leading PSG platforms: Sandman, REMbrandt, and RemLogic, and Enterprise Sleep Business Management Systems. This breadth of product offerings provides a unique set of tools to help optimize the efficiency of sleep labs.

Published: 16 September 2011
Written by Editor
Nasdaq   Healthcare   M & A   Up on News   Interesting News  
Read more: Natus Medical Incorporated ( BABY )

Dr. Fred Ueland Presents Positive Data on Combining OVA1® with Imaging

-- Demonstrates Sensitivity of 98.1% for All Types of Ovarian Cancers --

Fred Ueland, M.D., Associate Professor of Gynecologic Oncology at the University of Kentucky's Markey Cancer Center, and principal investigator of the multi-center OVA1 clinical trial, today presented data demonstrating the improvement in sensitivity when using imaging in conjunction with OVA1. These data were highlighted at the 17th Annual European Society of Gynecologic Oncology (ESGO) meeting being held in Milan from September 11th to 14th.

Published: 14 September 2011
Written by editor
Nasdaq   Healthcare   Project Updates   Up on News   Interesting News  
Read more: Vermillion Inc ( VRML )

FDA Clears IsoRay's GliaSite® Treatment for Brain Cancer

World's Only Liquid Radiation Balloon Catheter Device Treats Glioblastomas and Metastasized Brain Cancers

IsoRay, Inc. (Amex:ISR - News) announced today that the FDA has cleared its GliaSite® radiation therapy system, a balloon catheter device used in the treatment of brain cancer. The clearance was the major step required to return the GliaSite® radiation therapy system to the marketplace. The system’s balloon catheter is a landmark technology that allows physicians to treat more brain cancer patients than ever before with internal radiation or brachytherapy.

Published: 12 September 2011
Written by Editor
AMEX   Healthcare   FDA HC Decision   Up on News   Interesting News  
Read more: IsoRay Inc ( ISR )

MELA Sciences Receives European Union Approval for MelaFind(R)

Company Plans to Initially Launch MelaFind in Germany

MELA Sciences (NASDAQ: MELA - News) today announced that it received CE Mark approval for MelaFind®, allowing the company to market its MelaFind device to dermatologists across the European Union (EU).   The company intends to initially market MelaFind in Germany, which has the highest incidence of melanoma in Europe.

The CE (Conformité Européenne, or "European Conformity") Mark approval allows the company to market MelaFind freely across the 27 nations that comprise the EU.   The EU is the world's largest economic bloc with over 500 million residents and annual economic output of over $16 trillion.

Published: 07 September 2011
Written by Editor
Nasdaq   Healthcare   Project Updates   Up on News   Interesting News  
Read more: MELA Sciences ( MELA )
  1. Stereotaxis Inc ( STXS )
  2. Biotech/Medical Technology Stock News; Aethlon Medical (OTCBB: AEMD) Announces Sarcoma, Lung Cancer, Prostate Cancer, Metastatic Melanoma, and Head and Neck Cancer Studies
  3. Toumaz Limited Announces Joint Venture For Newly Approved Sensium™ “Digital Plaster”
  4. Verisante Technology Inc ( VRS )
  5. PURE Bioscience Inc ( PURE )